title: [Termination of pregnancy with 16,16-dimethyl-trans-delta2 PGE1 methyl ester vaginal suppositories: an analysis of 182 cases].
authors.forename: M K
authors.initials: MK
authors.lastname: Du
authors.forename: Y D
authors.initials: YD
authors.lastname: Ying
authors.forename: H M
authors.initials: HM
authors.lastname: Zheng
authors.forename: Y E
authors.initials: YE
authors.lastname: Yuan
authors.forename: Y
authors.initials: Y
authors.lastname: Zhu
mesh_terms: D000019:Abortifacient Agents; D000028:Abortion, Induced; D001695:Biology; D003267:Contraception; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005313:Fetal Death; D010570:Pessaries; D010827:Physiology; D011248:Pregnancy Complications; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D011453:Prostaglandins; D013089:Spermatocidal Agents
chemical_list: D000019:Abortifacient Agents; D011453:Prostaglandins; D013089:Spermatocidal Agents
keywords: Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Biology; Contraception; Contraceptive Methods; Endocrine System; Evaluation; Family Planning; Fertility Control, Postconception; Fetal Death; Physiology; Pregnancy Complications; Pregnancy, First Trimester; Pregnancy, Second Trimester; Pregnancy, Third Trimester; Prostaglandins--administraction and dosage; Vaginal Spermicides; Vaginal Suppository